OSTEONECROSE DOS MAXILARES RELACIONADA A BISFOSFONATOS

PROTOCOLO CLÍNICO E DESAFIOS NAS EXTRAÇÕES DENTÁRIAS.

Authors

  • Jáder Oliveira da Costa Filho Afya Uninovafapi
  • João Paulo Marques Sousa Afya Uninovafapi
  • Eduardo Souza de Lobão Veras
  • Matheus Araújo Brito Santos Lopes
  • Erik Neiva Ribeiro de Carvalho Reis
  • Elesbão Ferreira Viana Junior

DOI:

https://doi.org/10.36557/2674-8169.2025v7n10p1684-1699

Keywords:

Tooth Extraction, , Bisphosphonates, Osteonecrosis

Abstract

This study aimed to analyze, through an integrative literature review, the main recommendations, clinical protocols, and therapeutic strategies related to tooth extractions in patients using bisphosphonates who are at risk of developing medication-related osteonecrosis of the jaws (MRONJ). This is a complex condition that requires a multidisciplinary approach and careful planning to minimize complications and preserve patients’ quality of life.

The methodology involved a systematic search in the PubMed, SciELO, and Virtual Health Library databases, conducted between February and June 2025, using the descriptors “Tooth extraction,” “Bisphosphonates,” “Osteonecrosis of the jaws,” and “Treatment.” Original and review articles published between 2015 and 2025, in Portuguese and English, available in full text, and directly addressing the topic were included. The selection and analysis of studies followed the PICO strategy, considering population, intervention, comparison, and outcome.

The results showed that bisphosphonate-related osteonecrosis of the jaws is a multifactorial complication frequently associated with invasive dental procedures, particularly tooth extractions. The risk is closely related to the route of administration, duration of drug use, presence of local infections, comorbidities, and lack of prior dental assessment. The literature emphasizes the importance of preventive measures such as dental evaluation before therapy initiation, minimally invasive surgical techniques, primary wound closure, prophylactic antibiotic use, laser therapy, and strict postoperative follow-up.

Recent studies also highlight the potential of adjuvant therapies such as teriparatide, biomaterials, and exosomes, which have shown promising results in bone regeneration and inflammation control. It is concluded that prevention and individualized treatment planning are essential for the clinical management of these patients. The integration among dentists, physicians, and other healthcare professionals is crucial to reducing risks and ensuring a safe and effective therapeutic outcome.

Downloads

Download data is not yet available.

References

ALBLAZI, Kamila et al. Potential role of comprehensive dental care in preventing medication related osteonecrosis of the jaw (MRONJ): a single centre study. BMC Oral Health, v. 24, n. 1, p. 1291, 2024.

AL-SARRAJ, Mariam; BURNS, Megan; PATEL, Vinod. Pre-existing medication-related osteonecrosis of the jaw before dental extraction. British Dental Journal, v. 235, n. 10, p. 783-788, 2023.

DE FREITAS, Larissa Couto et al. Medication-related osteonecrosis of the jaw in an older patient with multiple myeloma. Gerodontology, v. 42, n. 1, p. 119-123, 2025.

DIOGUARDI, M. et al. Oral bisphosphonate-induced osteonecrosis complications in patients undergoing tooth extraction: a systematic review and literature updates. European Review for Medical and Pharmacological Sciences, v. 27, n. 13, p. 6359-6373, 2023.

FERNANDES, José Pedro Mateus. The effectiveness of teriparatide in the treatment of medication-related osteonecrosis of the jaw: Narrative review. PQDT-Global, 2023.

FUNAYAMA, Naoki et al. Impact of beta-tricalcium phosphate on preventing tooth extraction triggered bisphosphonate-related osteonecrosis of the jaw in rats. Scientific Reports, v. 13, n. 1, p. 16032, 2023.

KOMATSU, Yuko et al. Risk factors of medication-related osteonecrosis of the jaw: A clinical investigation. Journal of Stomatology, Oral and Maxillofacial Surgery, v. 125, n. 6, p. 101791, 2024.

KÜN-DARBOIS, J.-D.; FAUVEL, F. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management. Morphologie, v. 105, n. 349, p. 170-187, 2021.

NAKASHIMA, Fuminori et al. Role of sclerostin deletion in bisphosphonate-induced osteonecrosis of the jaw. Bone, v. 187, p. 117200, 2024.

PARK, Jung-Hyun et al. Time since last intravenous bisphosphonate and risk of osteonecrosis of the jaw in osteoporotic patients. Nature Communications, v. 16, n. 1, p. 4367, 2025.

SANDA, Koma et al. Therapeutic effect of fluvastatin on medication-related osteonecrosis of the jaw. Journal of periodontology, v. 93, n. 6, p. 837-846, 2022.

SCHWECH, Nurda; NILSSON, Johanna; GABRE, Pia. Incidence and risk factors for medication related osteonecrosis after tooth extraction in cancer patients—A systematic review. Clinical and Experimental Dental Research, v. 9, n. 1, p. 55-65, 2023.

Somay E. Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int. 2023 Oct;34(10):1811-1812. doi: 10.1007/s00198-023-06821-8. Epub 2023 Jul 7. PMID: 37418153.

YOO, Jin-Joo et al. Risk of bisphosphonate-related osteonecrosis of the jaw in implants vs. extractions: a nationwide population-based study. Clinical Oral Investigations, v. 29, n. 7, p. 1-9, 2025.

ZHENG, Yi et al. Exosomes from Adipose-Derived mesenchymal stromal cells prevent Medication-Related osteonecrosis of the jaw by inhibiting macrophage M1 polarization and pyroptosis. International Journal of Nanomedicine, p. 12675-12693, 2024.

Published

2025-10-27

How to Cite

Costa Filho , J. O. da, Sousa, J. P. M., Veras, E. S. de L., Lopes, M. A. B. S., Reis , E. N. R. de C., & Viana Junior , E. F. (2025). OSTEONECROSE DOS MAXILARES RELACIONADA A BISFOSFONATOS: PROTOCOLO CLÍNICO E DESAFIOS NAS EXTRAÇÕES DENTÁRIAS. Brazilian Journal of Implantology and Health Sciences, 7(10), 1684–1699. https://doi.org/10.36557/2674-8169.2025v7n10p1684-1699